Arbutus Biopharma ABUS
NASDAQ ABUS
$4.56 -0.22 (-4.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

Arbutus Biopharma (ABUS) Depreciation & Amortization - Total (2013 - 2021)

Updated

Arbutus Biopharma (ABUS) posted Depreciation & Amortization - Total of $447,000 for Q3 2021, down 8.8% from $490,000 a year earlier but up 2.5% from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Depreciation & Amortization - Total (2013 - 2021) Analysis & Trends

For the trailing twelve months through Sep 30, 2021, Depreciation & Amortization - Total at Arbutus Biopharma was $1.81 million, down 9.3% year-over-year; for FY2020, it was $1.98 million, down 2.5% from FY2019.

  • Annual Depreciation & Amortization - Total shows a five-year compound annual growth rate of 27.4% (FY2015 to FY2020).
  • In prior years, Arbutus Biopharma's Depreciation & Amortization - Total was $2.03 million in FY2019 (-7.0%), $2.18 million in FY2018 (+7.6%), $2.03 million in FY2017 (+85.6%) and $1.09 million in FY2016 (+85.4%).
  • Quarterly Depreciation & Amortization - Total has run from a low of $332,000 in Q4 2016 to a high of $620,000 in Q4 2017 over five years.
  • On a year-over-year basis, Depreciation & Amortization - Total has declined in each of the last seven quarters, with an average decline of 5.3% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization - Total in the past five years was Q3 2017, with growth of 103.8%; the weakest was Q4 2018, with a decline of 18.7%.
  • According to Business Quant data, Depreciation & Amortization - Total for the three prior quarters was $436,000 (Q2 2021), $443,000 (Q1 2021) and $487,000 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Arbutus Biopharma 944.69 Mn 571.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 447,000.00
Jun 30, 2021 436,000.00
Mar 31, 2021 443,000.00
Dec 31, 2020 487,000.00
Sep 30, 2020 490,000.00
Jun 30, 2020 501,000.00
Mar 31, 2020 500,000.00
Dec 31, 2019 507,000.00
Sep 30, 2019 507,000.00
Jun 30, 2019 505,000.00
Mar 31, 2019 509,000.00
Dec 31, 2018 504,000.00
Sep 30, 2018 497,000.00
Jun 30, 2018 578,000.00
Mar 31, 2018 602,000.00
Dec 31, 2017 620,000.00
Sep 30, 2017 593,000.00
Jun 30, 2017 480,000.00
Mar 31, 2017 334,000.00
Dec 31, 2016 332,000.00
API Access

Arbutus Biopharma Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=ABUS&period=max&api_key=YOUR_API_KEY